TrialInternational journal of oncology2012

Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma.

Fujimasa Tada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.